Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Irritable Bowel Syndrome, September 2021

Free Subscription


Abstracts

Retrieve all available abstracts of the following 72 articles:
HTML format


 

Single Articles

  1. GUO J, Yang L, He J, Yang Z, et al
    Comparison of therapeutic effects of different acupuncture and moxibustion therapies on irritable bowel syndrome: A protocol for systematic review and network meta-analysis.
    Medicine (Baltimore). 2021;100:e26920.
    PubMed    
    Abstract available

  2. SALEHIAN R, Mokhtare M, Ghanbari Jolfaei A, Noorian R, et al
    Investigation the Effectiveness of Duloxetine in Quality of Life and Symptoms of Patients with Irritable Bowel Syndrome.
    Adv Biomed Res. 2021;10:14.
    PubMed    
    Abstract available

  3. HU Y, Chen F, Ye H, Lu B, et al
    Integrative analysis of the gut microbiome and metabolome in a rat model with stress induced irritable bowel syndrome.
    Sci Rep. 2021;11:17596.
    PubMed    
    Abstract available

  4. FAIRBRASS KM, Selinger CP, Gracie DJ, Ford AC, et al
    Prevalence and impact of Rome IV versus Rome III irritable bowel syndrome in patients with inflammatory bowel disease.
    Neurogastroenterol Motil. 2021 Sep 1:e14256. doi: 10.1111/nmo.14256.
    PubMed    
    Abstract available

  5. KHANNA S, Mukewar SV, Jagtap S, Khaliq A, et al
    Sociodemographic and Clinical Profiles of Patients with Irritable Bowel Syndrome: A Cross-sectional, Multi-centric, Epidemiological Study in India.
    J Assoc Physicians India. 2021;69:11-12.
    PubMed    
    Abstract available

  6. WEERTS ZZRM, Essers BAB, Jonkers DMAE, Willems JIA, et al
    A trial-based economic evaluation of peppermint oil for the treatment of irritable bowel syndrome.
    United European Gastroenterol J. 2021 Sep 1. doi: 10.1002/ueg2.12134.
    PubMed    
    Abstract available

  7. BLACKETT JW, Li J, Jodorkovsky D, Freedberg DE, et al
    Prevalence and risk factors for gastrointestinal symptoms after recovery from COVID-19.
    Neurogastroenterol Motil. 2021 Sep 1:e14251. doi: 10.1111/nmo.14251.
    PubMed    
    Abstract available

  8. BONETTO S, Fagoonee S, Battaglia E, Grassini M, et al
    Recent advances in the treatment of irritable bowel syndrome.
    Pol Arch Intern Med. 2021;131.
    PubMed    
    Abstract available

  9. PETERS S, Pascoe B, Wu Z, Bayliss SC, et al
    Campylobacter jejuni genotypes are associated with post-infection irritable bowel syndrome in humans.
    Commun Biol. 2021;4:1015.
    PubMed    
    Abstract available

  10. VORK L, Penders J, Jalanka J, Bojic S, et al
    Does Day-to-Day Variability in Stool Consistency Link to the Fecal Microbiota Composition?
    Front Cell Infect Microbiol. 2021;11:639667.
    PubMed    
    Abstract available

  11. VAN DER GEEST AM, Besseling-van der Vaart I, Schellinger-de Goede EM, van der Waal MB, et al
    Multispecies probiotics promote perceived human health and wellbeing: insights into the value of retrospective studies on user experiences.
    Benef Microbes. 2021 Aug 30:1-18. doi: 10.3920/BM2020.0162.
    PubMed    
    Abstract available

  12. NOWAK JK, Nowak R, Radzikowski K, Grulkowski I, et al
    Automated Bowel Sound Analysis: An Overview.
    Sensors (Basel). 2021;21.
    PubMed    
    Abstract available

  13. GORDON JB
    The importance of child abuse and neglect in adult medicine.
    Pharmacol Biochem Behav. 2021 Sep 6:173268. doi: 10.1016/j.pbb.2021.173268.
    PubMed    
    Abstract available

  14. WEAVER KR, Mustapic M, Kapogiannis D, Henderson WA, et al
    Neuronal-enriched extracellular vesicles in individuals with IBS: A pilot study of COMT and BDNF.
    Neurogastroenterol Motil. 2021 Sep 9:e14257. doi: 10.1111/nmo.14257.
    PubMed    
    Abstract available

  15. QUAGHEBEUR J, Petros P, Wyndaele JJ, De Wachter S, et al
    Pelvic-floor function, dysfunction, and treatment.
    Eur J Obstet Gynecol Reprod Biol. 2021;265:143-149.
    PubMed    
    Abstract available

  16. SHI H, Niu Y, Huang Q, Yang ZM, et al
    [Diarrhea-predominant irritable bowel syndrome of spleen deficiency and damp excess treated with fire needling therapy with filiform needle and acupoint application therapy: a randomized controlled trial].
    Zhongguo Zhen Jiu. 2021;41:984-90.
    PubMed    
    Abstract available

  17. WANG J, Yang P, Zhang L, Hou X, et al
    A Low-FODMAP Diet Improves the Global Symptoms and Bowel Habits of Adult IBS Patients: A Systematic Review and Meta-Analysis.
    Front Nutr. 2021;8:683191.
    PubMed    
    Abstract available

  18. CHEN X, Yu X, Shi Y, Shen H, et al
    Overview of systematic evaluation of efficacy of Tongxie Yaofang in treating diarrhea-predominant irritable bowel syndrome.
    Ann Palliat Med. 2021;10:9249-9258.
    PubMed    
    Abstract available

  19. JANDAGHI G, Zia-Tohidi A, Firoozi M
    Psychological Interventions for Irritable Bowel Syndrome: A Meta-Analysis of Iranian Randomized Trials.
    Arch Iran Med. 2021;24:496-504.
    PubMed    
    Abstract available

  20. VALIDO E, Stoyanov J, Bertolo A, Hertig-Godeschalk A, et al
    Systematic Review of the Effects of Oat Intake on Gastrointestinal Health.
    J Nutr. 2021 Sep 6. pii: 6364878. doi: 10.1093.
    PubMed    
    Abstract available

  21. HERRERA G, Paredes-Sabja D, Patarroyo MA, Ramirez JD, et al
    Updating changes in human gut microbial communities associated with Clostridioides difficile infection.
    Gut Microbes. 2021;13:1966277.
    PubMed    
    Abstract available

  22. VAJRAVELU RK, Shapiro JM, Ni J, Thanawala SU, et al
    Risk for Post-Colonoscopy Irritable Bowel Syndrome in Patients with and without Antibiotic Exposure: A Retrospective Cohort Study.
    Clin Gastroenterol Hepatol. 2021 Sep 2. pii: S1542-3565(21)00929.
    PubMed    
    Abstract available

  23. LEVY EI, De Geyter C, Ouald Chaib A, Aman BA, et al
    How to manage irritable bowel syndrome in children.
    Acta Paediatr. 2021 Sep 15. doi: 10.1111/apa.16107.
    PubMed    
    Abstract available

  24. PESCE M, Puoti MG, Rybak A, Andreozzi M, et al
    Pharmacological intervention for paediatric irritable bowel syndrome.
    Expert Opin Pharmacother. 2021 Sep 15. doi: 10.1080/14656566.2021.1976753.
    PubMed    
    Abstract available

  25. RANGAN V, Singh P, Ballou S, Hassan R, et al
    Improvement in constipation and diarrhea is associated with improved abdominal pain in patients with functional bowel disorders.
    Neurogastroenterol Motil. 2021 Sep 14:e14253. doi: 10.1111/nmo.14253.
    PubMed    
    Abstract available

  26. ZHAO J, Chen M, Wang X, Ye K, et al
    Efficacy of acupuncture in refractory irritable bowel syndrome: study protocol for a randomised controlled trial.
    BMJ Open. 2021;11:e045655.
    PubMed    
    Abstract available

  27. SABO CM, Dumitrascu DL
    Microbiota and the irritable bowel syndrome.
    Minerva Gastroenterol (Torino). 2021 Sep 13. pii: S2724-5985.21.02923.
    PubMed    
    Abstract available

  28. ALSHARIF NM, Omeish H, Abdulelah M, Abu-Rumaileh MA, et al
    Anorectal Melanoma: An Uncommon Cause of Lower Gastrointestinal Bleeding.
    Cureus. 2021;13:e16821.
    PubMed    
    Abstract available

  29. KITSELAAR WM, van der Vaart R, van Tilborg-den Boeft M, Vos HMM, et al
    The general practitioners perspective regarding registration of persistent somatic symptoms in primary care: a survey.
    BMC Fam Pract. 2021;22:182.
    PubMed    
    Abstract available

  30. CHAI Y, Lu Y, Yang L, Qiu J, et al
    Identification and potential functions of tRNA-derived small RNAs (tsRNAs) in irritable bowel syndrome with diarrhea.
    Pharmacol Res. 2021 Sep 9:105881. doi: 10.1016/j.phrs.2021.105881.
    PubMed    
    Abstract available

  31. PAULO AFS, Bau TR, Ida EI, Shirai MA, et al
    Edible coatings and films with incorporation of prebiotics -A review.
    Food Res Int. 2021;148:110629.
    PubMed    
    Abstract available

  32. PRAMESWARI HS, Balakrishnan ID, Khoo CY, Teo LY, et al
    The role of multimodality imaging in diagnosing acute perimyocarditis secondary to Crohn's disease.
    BMC Cardiovasc Disord. 2021;21:427.
    PubMed    
    Abstract available

  33. SHAKYA S
    Irritable Bowel Syndrome and Me: A Sworn Rivalry.
    JNMA J Nepal Med Assoc. 2021;59:303-304.
    PubMed    
    Abstract available

  34. DEVULAPALLI CS
    Gluten-free diet in children: a fad or necessity?
    Arch Dis Child. 2021;106:628-629.
    PubMed    


  35. ALGERA JP, Storsrud S, Lindstrom A, Simren M, et al
    Gluten and fructan intake and their associations with gastrointestinal symptoms in irritable bowel syndrome: A food diary study.
    Clin Nutr. 2021;40:5365-5372.
    PubMed    
    Abstract available

  36. EJOVA A, Badcock NA, McKerchar S, Beath AP, et al
    Electroencephalographic evidence of unconscious and conscious attentional bias in people with functional gastrointestinal disorders: A pilot study.
    Int J Psychophysiol. 2021 Sep 21. pii: S0167-8760(21)00884.
    PubMed    
    Abstract available

  37. LIPTAK R, Gromova B, Gardlik R
    Fecal Microbiota Transplantation as a Tool for Therapeutic Modulation of Non-gastrointestinal Disorders.
    Front Med (Lausanne). 2021;8:665520.
    PubMed    
    Abstract available

  38. RUSCHIL V, Mazurak N, Hofmann M, Loskutova E, et al
    Decreased Autonomic Reactivity and Psychiatric Comorbidities in Neurological Patients With Medically Unexplained Sensory Symptoms: A Case-Control Study.
    Front Neurol. 2021;12:713391.
    PubMed    
    Abstract available

  39. MURRAY HB, Staller K
    When food moves from friend to foe: Why avoidant/restrictive food intake matters in irritable bowel syndrome.
    Clin Gastroenterol Hepatol. 2021 Sep 20. pii: S1542-3565(21)01031.
    PubMed    


  40. SCOTT MJ, Crawford JS, Geraghty KJ, Marks DF, et al
    The 'medically unexplained symptoms' syndrome concept and the cognitive-behavioural treatment model.
    J Health Psychol. 2021 Sep 23:13591053211038042. doi: 10.1177/13591053211038042.
    PubMed    
    Abstract available

  41. VON SCHASSEN H, Andresen V, Layer P
    [The new guideline on irritable bowel syndrome: what is new?]
    Dtsch Med Wochenschr. 2021;146:1243-1248.
    PubMed    
    Abstract available

  42. JEITLER M, Wottke T, Schumann D, Puerto Valencia LM, et al
    Ayurvedic vs. Conventional Nutritional Therapy Including Low-FODMAP Diet for Patients With Irritable Bowel Syndrome-A Randomized Controlled Trial.
    Front Med (Lausanne). 2021;8:622029.
    PubMed    
    Abstract available

  43. GALICA AN, Galica R, Dumitrascu DL
    Epidemiology of Irritable Bowel Syndrome in Albania.
    J Gastrointestin Liver Dis. 2021;30:334-338.
    PubMed    
    Abstract available

  44. WONGTRAKUL W, Charoenngam N, Ungprasert P
    The association between irritable bowel syndrome and ischemic colitis: a systematic review and meta-analysis.
    Minerva Gastroenterol (Torino). 2021 Sep 22. pii: S2724-5985.21.02957.
    PubMed    
    Abstract available

  45. STURKENBOOM R, Keszthelyi D, Brandts L, Weerts ZZRM, et al
    The estimation of a preference-based single index for the IBS-QoL by mapping to the EQ-5D-5L in patients with irritable bowel syndrome.
    Qual Life Res. 2021 Sep 21. pii: 10.1007/s11136-021-02995.
    PubMed    
    Abstract available

  46. CHEN GR, Xie XF, Peng C
    Treatment of Irritable Bowel Syndrome by Chinese Medicine: A Review.
    Chin J Integr Med. 2021 Sep 21. pii: 10.1007/s11655-021-3521.
    PubMed    
    Abstract available

  47. PRADEEP S, Mehanna R
    Gastrointestinal disorders in hyperkinetic movement disorders and ataxia.
    Parkinsonism Relat Disord. 2021 Sep 14. pii: S1353-8020(21)00334.
    PubMed    
    Abstract available

  48. NILSSON D, Ohlsson B
    Gastrointestinal Symptoms and Irritable Bowel Syndrome Are Associated With Female Sex and Smoking in the General Population and With Unemployment in Men.
    Front Med (Lausanne). 2021;8:646658.
    PubMed    
    Abstract available

  49. BOR S, Lehert P, Chalbaud A, Tack J, et al
    Efficacy of pinaverium bromide in the treatment of irritable bowel syndrome: a systematic review and meta-analysis.
    Therap Adv Gastroenterol. 2021;14:17562848211033740.
    PubMed    
    Abstract available

  50. XU G, Xing G, Zhang B, Zhu J, et al
    The Relieving Effects of a Polyherb-Based Dietary Supplement ColonVita on Gastrointestinal Quality of Life Index (GIQLI) in Older Adults with Chronic Gastrointestinal Symptoms Are Influenced by Age and Cardiovascular Disease: A 12-Week Randomized Plac
    Evid Based Complement Alternat Med. 2021;2021:6653550.
    PubMed    
    Abstract available

  51. CHEN XF, Guo Y, Lu XQ, Qi L, et al
    Aberrant Intraregional Brain Activity and Functional Connectivity in Patients With Diarrhea-Predominant Irritable Bowel Syndrome.
    Front Neurosci. 2021;15:721822.
    PubMed    
    Abstract available

  52. XU X, Dong Q, Zhong Q, Xiu W, et al
    The Flavonoid Kurarinone Regulates Macrophage Functions via Aryl Hydrocarbon Receptor and Alleviates Intestinal Inflammation in Irritable Bowel Syndrome.
    J Inflamm Res. 2021;14:4347-4359.
    PubMed    
    Abstract available

  53. KURIN M, Elangovan A, Alikhan MM, Al Dulaijan B, et al
    Irritable bowel syndrome is strongly associated with the primary and idiopathic mast cell disorders.
    Neurogastroenterol Motil. 2021 Sep 17:e14265. doi: 10.1111/nmo.14265.
    PubMed    
    Abstract available

  54. DI MICHELE F
    Why use nutraceutical strategies for the Irritable Bowel Syndrome.
    Curr Med Chem. 2021 Sep 16. pii: CMC-EPUB-118006.
    PubMed    
    Abstract available

  55. GOODOORY VC, Houghton LA, Black CJ, Ford AC, et al
    Characteristics of, and natural history among, individuals with Rome IV functional bowel disorders.
    Neurogastroenterol Motil. 2021 Sep 16:e14268. doi: 10.1111/nmo.14268.
    PubMed    
    Abstract available

  56. ZHONG LLD, Lam TF, Yang W, Zheng Y, et al
    Electro-acupuncture for irritable bowel syndrome patients: study protocol for a single-blinded randomized sham-controlled clinical trial.
    Trials. 2021;22:619.
    PubMed    
    Abstract available

  57. SJOLUND J, Kull I, Bergstrom A, Jaras J, et al
    Allergy-related diseases in childhood and risk for abdominal pain-related functional gastrointestinal disorders at 16 years-a birth cohort study.
    BMC Med. 2021;19:214.
    PubMed    
    Abstract available

  58. AHMED H, Hallam R, Webster G, Rej A, et al
    NCGS like IBS 'type' symptoms is a diagnosis of exclusion.
    Nutr J. 2021;20:79.
    PubMed    


  59. NICKERSON AJ, Rajendran VM
    Flupirtine enhances NHE-3-mediated Na(+) absorption in rat colon via an ENS-dependent mechanism.
    Am J Physiol Gastrointest Liver Physiol. 2021;321:G185-G199.
    PubMed    
    Abstract available

  60. LUO H, Vong CT, Tan D, Zhang J, et al
    Panax notoginseng Saponins Modulate the Inflammatory Response and Improve IBD-Like Symptoms via TLR/NF-[Formula: see text]B and MAPK Signaling Pathways.
    Am J Chin Med. 2021;49:925-939.
    PubMed    
    Abstract available

  61. GROVER M, Berumen A, Peters S, Wei T, et al
    Intestinal chemosensitivity in irritable bowel syndrome associates with small intestinal TRPV channel expression.
    Aliment Pharmacol Ther. 2021 Sep 2. doi: 10.1111/apt.16591.
    PubMed    
    Abstract available

  62. CHANG L, Lacy BE, Moshiree B, Kassebaum A, et al
    Efficacy of Linaclotide in Reducing Abdominal Symptoms of Bloating, Discomfort, and Pain: A Phase 3B Trial Using a Novel Abdominal Scoring System.
    Am J Gastroenterol. 2021;116:1929-1937.
    PubMed    
    Abstract available

  63. KAMBOJ AK, Agarwal S, Chedid VG, Iyer PG, et al
    Changes in National Google Trends and Local Healthcare Utilization After High-Impact Gastroenterology Publications.
    Am J Gastroenterol. 2021 Sep 16. pii: 00000434-990000000-00105.
    PubMed    
    Abstract available

  64. CHAUHAN A, Das P, Singh A, Dutta R, et al
    Pan-Gastrointestinal Tract Mucosal Pathologies in Patients with Celiac Disease with the Demonstration of IgA Anti-Transglutaminase Mucosal Deposits: A Case-Control Study.
    Dig Dis Sci. 2021 Sep 9. pii: 10.1007/s10620-021-07246.
    PubMed    
    Abstract available

  65. ANYANE-YEBOA A, Li B, Traboulsi C, Erondu AI, et al
    Black Race and Public Insurance Are Predictive of Inappropriate Evaluation of Iron Deficiency Anemia and Diarrhea.
    Dig Dis Sci. 2021;66:2200-2206.
    PubMed    
    Abstract available

  66. KEEFER L, Ballou SK, Drossman DA, Ringstrom G, et al
    A Rome Working Team Report on Brain-Gut Behavior Therapies for Disorders of Gut-Brain Interaction.
    Gastroenterology. 2021 Sep 13. pii: S0016-5085(21)03494.
    PubMed    
    Abstract available

  67. VERBEKE K
    Combining dietary fibres to reduce intestinal gas production in patients with IBS.
    Gut. 2021 Sep 23. pii: gutjnl-2021-325618. doi: 10.1136/gutjnl-2021-325618.
    PubMed    


  68. BOJARSKI C, Tangermann P, Barmeyer C, Buchkremer J, et al
    Prospective, double-blind diagnostic multicentre study of confocal laser endomicroscopy for wheat sensitivity in patients with irritable bowel syndrome.
    Gut. 2021 Sep 20. pii: gutjnl-2021-325181. doi: 10.1136/gutjnl-2021-325181.
    PubMed    
    Abstract available

  69. EL-SALHY M
    FMT in IBS: how cautious should we be?
    Gut. 2021;70:626-628.
    PubMed    


  70. JIANG Y, Kong H, Chang T, Bai T, et al
    Modified colonic transit test in healthy subjects and constipated patients: A triple-phase, two-center prospective study.
    J Gastroenterol Hepatol. 2021;36:959-967.
    PubMed    
    Abstract available

  71. COHEN MB, Gold BD, Xanthakos SA, CaJacob N, et al
    Intestinal Guanylate Cyclase-C mRNA Expression in Duodenum and Colon of Children.
    J Pediatr Gastroenterol Nutr. 2021 Sep 9. pii: 00005176-900000000-95545.
    PubMed    
    Abstract available

  72. THOMAZ DE ALMEIDA CN, Tahan S, Areco KN, Morais MB, et al
    Association between abuse and neglect with functional constipation and irritable bowel syndrome in adolescents.
    Scand J Gastroenterol. 2021 Sep 1:1-6. doi: 10.1080/00365521.2021.1923059.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;